Michael Auer

5PUBLICATIONS
25CO-AUTHORS
Central nervous systemApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)PharmacogenomicsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 29, 2022
Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) and Natalizumab Serum Concentration as Potential Biomarkers for Pharmacodynamics and Treatment Response of Patients with Multiple Sclerosis Receiving Natalizumab.

Michael Auer, Angelika Bauer, Antonia Oftring

|Apr 04, 2022
Recovery of Chronic Inflammatory Demyelinating Polyneuropathy on Treatment With Ocrelizumab in a Patient With Co-Existing Multiple Sclerosis.

Michael Auer, Harald Hegen, Anna Hotter

|Oct 30, 2020
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium.

Signe Hässler, Delphine Bachelet, Julianne Duhaze

|Jun 07, 2019
Conversion and reversion of anti-John Cunningham virus antibody serostatus: A prospective study.

Michael Auer, Harald Hegen, Johann Sellner

|Feb 10, 2018
Smoking is not associated with higher prevalence of JC virus in MS patients.

Michael Auer, Gabriel Bsteh, Harald Hegen

Pageof 1

Frequent Collaborators

1 joint publications

Signe Hässler

1 joint publications

Delphine Bachelet

1 joint publications

Julianne Duhaze

1 joint publications

Orhan Aktas